Nucleotide substitution: G?A.
Amino acid replacement: W559term.
G16627706A
G?A
W559term | Abl-PA; W577term | Abl-PB; W559term | Abl-PC; W577term | Abl-PD; W559term | Abl-PE; W577term | Abl-PF; W577term | Abl-PG; W559term | Abl-PH; W577term | Abl-PI; W559term | Abl-PJ
W559term
TGG to TGA nonsense mutation in codon W559.
abnormal cell size | P-stage (with Abl1)
abnormal neuroanatomy | embryonic stage (with Ablftz.PH), with AblKN.ftz
abnormal neuroanatomy | P-stage (with Abl1)
partially lethal (with Df(3L)st-j7)
actin cytoskeleton | P-stage (with Abl1)
adherens junction | P-stage (with Abl1)
apical part of cell | P-stage (with Abl1)
basal part of cell | P-stage (with Abl1)
eye photoreceptor cell | P-stage (with Abl1)
filamentous actin | P-stage (with Abl1)
interommatidial cell | P-stage (with Abl1)
larval longitudinal connective | embryonic stage (with Ablftz.PH), with AblKN.ftz
ommatidium | P-stage (with Abl1)
secondary pigment cell | P-stage (with Abl1)
stress fiber | P-stage (with Abl1)
Abl2 mutant embryos exhibit mild commissural defects.
In Abl2 mutant embryos, RP2 motoneurons frequently stall prior to reaching their targets in the ventral body wall muscles (6,7, 12 and 13).
Expression of AblN.Scer\UAS.T:Avic\GFP under the control of Scer\GAL4exex-Gal4 exacerbates the ISNb stalling phenotypes found in Abl2 mutant embryos.
Abl mutant flies are fully viable and do not display and PCP defects.
Approximately 9% of Abl2 mutant embryos display a duplication of the RP2 neuron in one hemisegment and have one missing in the contralateral segment. RP2 neurons in embryos mutant for the maternal as well as the zygotic Abl gene product (derived from females containing homozygous germline clones mated to homozygous males) fail to migrate completely, remaining in the location where the parent GMC-1 forms. This phenotype is almost fully penetrant.
90% of Abl1/Abl2 embryos hatch.
Abl2 homozygous embryos have intact commissures but show mild discontinuities in the longitudinal tracts.
Instead of forming an even plexus of growth cones at the lamina, photoreceptor axons in Abl1/Abl2 larvae fasciculate aberrantly to produce an irregular pattern of gaps and thickenings in the lamina, with a significant percentage of axon bundles failing to terminate properly at the lamina.
Whereas wild type and small Abl2 photoreceptor clones (generated via MARCM) exhibit normal axon targeting, large clones exhibit aberrant fasciculation and targeting to wild type brain tissue in third instar larvae. In contrast, wild type photoreceptor clones exhibit normal targeting to Abl2 brain tissue.
Homozygous embryos show axons ectopically crossing the midline. Mutant embryos occasionally show premature arrest of the ISNb axon, at either the muscle 6/7 or muscle 13 cleft.
In homozygous Abl2 stage 16 embryos, several axon bundles cross the midline incorrectly. Only a few embryos heterozygous for Abl2 exhibit axons abnormally crossing the midline, but greater than 50% of homozygous embryos exhibit on average two abnormal crossovers.
There are a few adult Abl2/Abl4 escapers that display a rough eye phenotype.
Expression of two copies of AblKN.ftz in Abl2 mutants results in all embryos exhibiting several axon bundles crossing the midline incorrectly.
ISNb growth cones fail to reach the distal target (muscle 12) in 24% of hemizygous embryos, although contacts with muscles 6,7 and 13 appear grossly normal. ISNb growth cones fail to reach the distal target (muscle 12) in 35% of Abl2/Abl4 embryos. Abl2/Abl4 embryos show mild defects in the Fas2-positive longitudinal fascicles of the central nervous system.
Shows 29% viability when heterozygous with Df(3L)st-j7.
Abl2 has abnormal neuroanatomy | embryonic stage phenotype, enhanceable by HemJ4-48
Abl2 has abnormal cell migration | embryonic stage phenotype, enhanceable by HemJ4-48
Abl2/Abl1 has partially lethal - majority live phenotype, enhanceable by eya[+]/eyaA188
Abl2/Abl1 has abnormal neuroanatomy | third instar larval stage phenotype, enhanceable by eya[+]/eyaA188
Abl2/Abl1 has partially lethal - majority live phenotype, enhanceable by eyaG130/eya[+]
Abl2 has abnormal neuroanatomy | embryonic stage phenotype, enhanceable by eya[+]/eyaA188
Abl2 has abnormal neuroanatomy | embryonic stage phenotype, enhanceable by eyaA188/eyaA188
Abl2 has abnormal neuroanatomy phenotype, enhanceable by chb4
Abl2 has abnormal neuroanatomy phenotype, enhanceable by chbP4
Abl2/Df(3L)st-j7 has lethal phenotype, enhanceable by Nl1N-ts1
Abl2 has abnormal neuroanatomy phenotype, non-enhanceable by Scer\GAL4eg-Mz360/fraΔC.UAS.Tag:HA
Abl2/Abl1 has abnormal neuroanatomy | P-stage phenotype, suppressible | partially by enaKK107752/Scer\GAL4elav.PLu
Abl2/Abl1 has abnormal cell size | P-stage phenotype, suppressible | partially by enaKK107752/Scer\GAL4elav.PLu
Abl2 has abnormal neuroanatomy | P-stage | somatic clone - tissue specific phenotype, suppressible | partially by ena23
Abl2 has abnormal neuroanatomy | embryonic stage 16 phenotype, suppressible by robo1UAS.cKa/Scer\GAL4ftz.ng
Abl2 has abnormal neuroanatomy | embryonic stage 16 phenotype, suppressible by robo1Y-F.UAS/Scer\GAL4ftz.ng
Abl2 has abnormal neuroanatomy phenotype, suppressible by Larbypass/Larbypass
Abl2/Abl1 has abnormal neuroanatomy | P-stage phenotype, non-suppressible by enaKK107752/Scer\GAL4LL54
Abl2/AblR297K.UAS.GFP has abnormal neuroanatomy phenotype, non-suppressible by Scer\GAL4eg-Mz360/fraΔC.UAS.Tag:HA
Abl2 has abnormal neuroanatomy phenotype, non-suppressible by Scer\GAL4eg-Mz360/fraΔC.UAS.Tag:HA
Abl2/Abl4 has abnormal neuroanatomy | embryonic stage phenotype, non-suppressible by DabUAS.cWa/Scer\GAL4elav.PU
Abl2/Abl[+] is an enhancer of abnormal neuroanatomy phenotype of fra6/fra3
Abl2 is an enhancer of abnormal neuroanatomy | embryonic stage phenotype of HemJ4-48
Abl2 is an enhancer of abnormal cell migration | embryonic stage phenotype of HemJ4-48
Abl2/Abl[+] is an enhancer of abnormal planar polarity phenotype of Scer\GAL4GMR.PF, cindrRNAi.PC.PD.UAS
Abl2 is an enhancer of abnormal neuroanatomy phenotype of chb4
Abl2 is an enhancer of abnormal neuroanatomy phenotype of chbP4
Abl2/Abl[+] is an enhancer of abnormal neuroanatomy phenotype of sli2
Abl2/Abl[+] is an enhancer of abnormal neuroanatomy phenotype of robo1unspecified, robo24
Abl2/Abl[+] is an enhancer of abnormal neuroanatomy phenotype of robo1unspecified, robo25
Abl2/Abl[+] is an enhancer of abnormal neuroanatomy phenotype of robo1unspecified, robo31
Scer\GAL4eg-Mz360, Abl2, AblK417N.UAS.GFP, Abl[+] is a non-enhancer of abnormal neuroanatomy phenotype of fra6/fra3
Abl2, dshY473F.EGFP, Abl[+] is a suppressor of lethal phenotype of dsh3
Abl2, eyaA188/eya2 has lethal - all die before end of larval stage phenotype
Abl3/Abl2, eyaA188/eya2 has lethal - all die before end of larval stage phenotype
Abl2/Abl4, Dscam1RNAi.UAS.19 has abnormal neuroanatomy | embryonic stage phenotype
Abl2/Abl4, Dscam1RNAi.UAS.18-20 has abnormal neuroanatomy | embryonic stage phenotype
Abl2/Abl4, Dscam1RNAi.UAS.18 has abnormal neuroanatomy | embryonic stage phenotype
Abl2, capt10 has abnormal neuroanatomy phenotype
Abl2, captk01217 has abnormal neuroanatomy phenotype
Abl2, capt10/capt[+] has abnormal neuroanatomy phenotype
Abl2, captk01217/capt[+] has abnormal neuroanatomy phenotype
Abl2 has larval RP2 motor neuron | embryonic stage phenotype, enhanceable by HemJ4-48
Abl2/Abl1 has lamina | third instar larval stage phenotype, enhanceable by eya[+]/eyaA188
Abl2 has larval ventral nerve cord | embryonic stage phenotype, enhanceable by eya[+]/eyaA188
Abl2 has larval ventral nerve cord | embryonic stage phenotype, enhanceable by eyaA188/eyaA188
Abl2 has larval intersegmental nerve phenotype, enhanceable by chb4
Abl2 has embryonic/larval neuron phenotype, enhanceable by chb4
Abl2 has embryonic/larval neuron phenotype, enhanceable by chbP4
Abl2 has larval EW neuron phenotype, non-enhanceable by Scer\GAL4eg-Mz360/fraΔC.UAS.Tag:HA
Abl2 has symmetrical commissure phenotype, non-enhanceable by Scer\GAL4eg-Mz360/fraΔC.UAS.Tag:HA
Abl2/Abl1 has eye photoreceptor cell | P-stage phenotype, suppressible | partially by enaKK107752/Scer\GAL4elav.PLu
Abl2/Abl1 has apical part of cell | P-stage phenotype, suppressible | partially by enaKK107752/Scer\GAL4elav.PLu
Abl2/Abl1 has actin cytoskeleton | P-stage phenotype, suppressible | partially by enaKK107752/Scer\GAL4elav.PLu
Abl2/Abl1 has secondary pigment cell | P-stage phenotype, suppressible | partially by enaKK107752/Scer\GAL4elav.PLu
Abl2/Abl1 has basal part of cell | P-stage phenotype, suppressible | partially by enaKK107752/Scer\GAL4elav.PLu
Abl2 has rhabdomere of eye photoreceptor cell | P-stage | somatic clone - tissue specific phenotype, suppressible | partially by ena23
Abl2 has eye photoreceptor cell | P-stage | somatic clone - tissue specific phenotype, suppressible | partially by ena23
Abl2 has filamentous actin | P-stage | somatic clone - tissue specific phenotype, suppressible | partially by ena23
Abl2 has larval longitudinal connective | embryonic stage 16 phenotype, suppressible by robo1UAS.cKa/Scer\GAL4ftz.ng
Abl2 has larval longitudinal connective | embryonic stage 16 phenotype, suppressible by robo1Y-F.UAS/Scer\GAL4ftz.ng
Abl2 has presumptive embryonic/larval central nervous system phenotype, suppressible by Larbypass/Larbypass
Abl2/Abl1 has basal part of cell | P-stage phenotype, non-suppressible by enaKK107752/Scer\GAL4LL54
Abl2/Abl1 has eye photoreceptor cell | P-stage phenotype, non-suppressible by enaKK107752/Scer\GAL4LL54
Abl2/AblR297K.UAS.GFP has larval EW neuron phenotype, non-suppressible by Scer\GAL4eg-Mz360/fraΔC.UAS.Tag:HA
Abl2/AblR297K.UAS.GFP has symmetrical commissure phenotype, non-suppressible by Scer\GAL4eg-Mz360/AblR297K.UAS.GFP/fraΔC.UAS.Tag:HA
Abl2 has larval EW neuron phenotype, non-suppressible by Scer\GAL4eg-Mz360/fraΔC.UAS.Tag:HA
Abl2 has symmetrical commissure phenotype, non-suppressible by Scer\GAL4eg-Mz360/fraΔC.UAS.Tag:HA
Abl2/Abl4 has larval intersegmental nerve branch ISNb of A1-7 phenotype, non-suppressible by DabUAS.cWa/Scer\GAL4elav.PU
Abl2/Abl[+] is an enhancer of larval EW neuron phenotype of fra6/fra3
Abl2/Abl[+] is an enhancer of symmetrical commissure phenotype of fra6/fra3
Abl2 is an enhancer of larval RP2 motor neuron | embryonic stage phenotype of HemJ4-48
Abl2/Abl[+] is an enhancer of ommatidium phenotype of Scer\GAL4GMR.PF, cindrRNAi.PC.PD.UAS
Abl2/Abl[+] is an enhancer of pigment cell phenotype of Scer\GAL4GMR.PF, cindrRNAi.PC.PD.UAS
Abl2/Abl[+] is an enhancer of cone cell phenotype of Scer\GAL4GMR.PF, cindrRNAi.PC.PD.UAS
Abl2 is an enhancer of embryonic/larval neuron phenotype of chbP4
Abl2 is an enhancer of larval intersegmental nerve phenotype of chb4
Abl2 is an enhancer of embryonic/larval neuron phenotype of chb4
Abl2/Abl[+] is an enhancer of presumptive embryonic/larval central nervous system phenotype of sli2
Abl2/Abl[+] is an enhancer of presumptive embryonic/larval central nervous system phenotype of robo1unspecified, robo24
Abl2/Abl[+] is an enhancer of presumptive embryonic/larval central nervous system phenotype of robo1unspecified, robo25
Abl2/Abl[+] is an enhancer of presumptive embryonic/larval central nervous system phenotype of robo1unspecified, robo31
Abl2/Abl[+] is an enhancer of larval longitudinal connective phenotype of chic05205a/chic221
Abl2/Abl4 is an enhancer of larval longitudinal connective phenotype of chic05205a/chic221
Scer\GAL4eg-Mz360, Abl2, AblK417N.UAS.GFP, Abl[+] is a non-enhancer of larval EW neuron phenotype of fra6/fra3
Scer\GAL4eg-Mz360, Abl2, AblK417N.UAS.GFP, Abl[+] is a non-enhancer of symmetrical commissure phenotype of fra6/fra3
Abl2 is a suppressor of larval intersegmental nerve phenotype of Larbypass/LarE55
Abl2 is a suppressor of larval intersegmental nerve phenotype of LarOD16/Lar13.2
Abl2, eya[+]/eyaA188 has larval ventral nerve cord commissure | embryonic stage phenotype
Abl2, eyaA188 has larval ventral nerve cord commissure | embryonic stage phenotype
Abl2/Abl4, Dscam1RNAi.UAS.19 has larval ventral nerve cord | embryonic stage phenotype
Abl2/Abl4, Dscam1RNAi.UAS.18-20 has larval ventral nerve cord | embryonic stage phenotype
Abl2/Abl4, Dscam1RNAi.UAS.18 has larval ventral nerve cord | embryonic stage phenotype
Abl2, captk01217 has presumptive embryonic/larval central nervous system phenotype
Abl2, capt10/capt[+] has presumptive embryonic/larval central nervous system phenotype
Abl2, captk01217/capt[+] has presumptive embryonic/larval central nervous system phenotype
Abl2, chic05205a/chic221 has larval longitudinal connective phenotype
Abl2, Nl1N-ts1 has larval longitudinal connective phenotype
Abl2, Nl1N-ts1 has larval intersegmental nerve | lateral phenotype
Abl2, Fas1TE89Da has axon phenotype
A Abl2/+ heterozygous background increases the number of segments displaying EW axon midline crossing defects in Df(1)NetABΔ stage 15 embryos from approximately 40% to 45% of segments.
Expression of a weak transgene of fraΔC.Scer\UAS.T:Ivir\HA1 under the control of Scer\GAL4eg-Mz360 has no effect on the number and severity of midline crossing defects found in Abl2 homozygous mutants.
Expression of AblR297K.Scer\UAS.T:Avic\GFP in the EW neurons of Abl2 mutant embryos fails to rescue the commissural defects found in Abl2 mutant embryos expressing fraΔC.Scer\UAS.T:Ivir\HA1.
Expression of a weak transgene of fraΔC.Scer\UAS.T:Ivir\HA1 under the control of Scer\GAL4eg-Mz360 has no effect on the number and severity of midline crossing defects found in Abl2 homozygous mutants. The presence of AblScer\UAS.T:Avic\GFP reduces the number of midline crossing defects (to a statistically significant level) in Abl2 homozygous mutants in a fraΔC.Scer\UAS.T:Ivir\HA1-expressing background. The presence of AblK417N.Scer\UAS.T:Avic\GFP reduces (although not to a statistically significant level) the number of midline crossing defects in Abl2 homozygous mutants in a fraΔC.Scer\UAS.T:Ivir\HA1-expressing background.
Expression of AblΔFABD.Scer\UAS.T:Avic\GFP in EW neurons, under the control of Scer\GAL4eg-Mz360 fails to rescue EW midline-crossing defects in Abl2 neurons expressing fraΔC.Scer\UAS.T:Ivir\HA1.
Expression of dshY473F.T:Avic\GFP-EGFP in a Abl2/+ mutant background partially rescues the lethality seen in dsh3. The PCP defects are not rescued.
The ISNb stall phenotype seen in Abl2/Abl4 embryos is not suppressed by expression of DabScer\UAS.cWa under the control of Scer\GAL4elav.PU.
eyaA188/+ or eyaG130/+ reduces the hatch rate of Abl1/Abl2 embryos from 90% to 20%.
Abl2, eyaA188/+ embryos have discontinuities along the longitudinal axon bundles with 20% of commissures lost or defective. Abl2, eyaA188 embryos show severe disruptions in the longitudinal tracts and 77% of commissures are lost.
The embryonic CNS of eyaA188, Abl2/+ is indistinguishable from wild type.
eyaA188/+ enhances the Abl1/Abl2 mistargeting phenotype, resulting in a highly disorganized lamina plexus.
Scer\GAL4tub.PU-mediated expression of Dscam1miRNA.Scer\UAS.18 in a Abl2/Abl4 background causes commisureless phenotypes in the ladder-like neuronal tracts in 19% of embryonic ventral ganglion segments.
Scer\GAL4tub.PU-mediated expression of Dscam1miRNA.Scer\UAS.19 in a Abl2/Abl4 background causes commisureless phenotypes in the ladder-like neuronal tracts in 9% of embryonic ventral ganglion segments.
Scer\GAL4tub.PU-mediated expression of Dscam1miRNA.Scer\UAS.18-20 in a Abl2/Abl4 background causes commisureless phenotypes in the ladder-like neuronal tracts in 1% of embryonic ventral ganglion segments.
An Abl2 heterozygous background enhances the patterning defects found in Scer\GAL4GMR.PF>cindrdsRNA.PC.PD.Scer\UAS mutants. The mean interommatidial precursor cell number and the number of cone and/or 1[o] cell errors is increased in these double mutants.
The frequency of axons ectopically crossing the midline in chbP4 Abl2 double homozygous embryos is substantially increased compared to the frequency seen in either single homozygote. The frequency of axons ectopically crossing the midline in chb4 Abl2 double homozygous embryos is substantially increased compared to the frequency seen in either single homozygote. chb4 Abl2 double homozygous embryos show an increased frequency of premature arrest of the ISNb axon compared to either single homozygote, with the arrest being seen at both the muscle 6/7 and the muscle 13 choice points.
Overexpression of roboScer\UAS.cKa under the control of Scer\GAL4ftz.ng in Abl2 homozygous mutants suppresses the frequency of abnormal crossovers observed in Abl2 mutants.
Overexpression of roboY-F.Scer\UAS under the control of Scer\GAL4ftz.ng in Abl2 homozygous mutants suppresses the frequency of abnormal crossovers observed in Abl2 mutants.
Central nervous system axons are seen to cross the midline in Abl2 captk01217 double heterozygous embryos. Central nervous system axons are seen to cross the midline in Abl2 capt10 double heterozygous embryos. Central nervous system axons are seen to cross the midline in Abl2 captE636 double heterozygous embryos. Expression of captScer\UAS.cBa under the control of Scer\GAL4elav.PLu completely rescues the midline crossing defects seen in captE636 Abl2 double heterozygotes. Expression of captC.Scer\UAS under the control of Scer\GAL4elav.PLu partially rescues the midline crossing defects seen in captE636 Abl2 double heterozygotes. The midline crossing errors seen in the central nervous system of Abl2/Abl2 embryos are suppressed by Larbypass/Larbypass. The frequency of ectopic crossing of the midline by axons in the central nervous system seen in sli2 heterozygous embryos is increased if they are also heterozygous for Abl2. The frequency of ectopic crossing of the midline by axons in the central nervous system seen in robounspecified learobo2-4 embryos is increased by Abl2/+. The frequency of ectopic crossing of the midline by axons in the central nervous system seen in robounspecified learobo2-5 embryos is increased by Abl2/+. The frequency of ectopic crossing of the midline by axons in the central nervous system seen in robounspecified robo31 embryos is increased by Abl2/+.
Viability of Abl2/Df(3L)st-j7 animals reduced to <1.0% when combined with Nl1N-ts1 at 18oC. Affected embryos do not show a neurogenic or antimyogenic phenotype. The gross morphology of the embryos is normal but they show axonal defects in all axon tracts known to require N function: CNS longitudinal tracts between neuromeres and the lateral portion of the ISN. Defects are evident from stage 13, in the combined MP fascicle. The nerve frays and stalls precisely as it attempts to grow along the trachea. The LG5 glial cell is present. Neurons aCC MP1 pCC dMP2 and vMP2 are all present. Pioneer neuron identity is unaffected (as assayed by ftz, eve, odd, Fas2 and pros expression).
The pupal lethality of hemizygous flies is not affected if the flies are also mutant for Ptp99A (Ptp99AHA64/Ptp99AR3.
Abl2, Fas1TE89Da mutant embryos exhibit gross defects in the developing CNS axon guidance and the morphogenesis of CNS axon tracts: an allele specific interaction.
Abl2 is rescued by Scer\GAL4exex-Gal4/AblUAS.GFP
Abl2 is rescued by AblR297K.UAS.GFP/Scer\GAL4exex-Gal4
Abl2 is rescued by AblΔFABD.UAS.GFP/Scer\GAL4exex-Gal4
Abl2/Abl1 is partially rescued by Scer\GAL4elav.PLu/AblUAS.GFP
Abl2/Abl1 is partially rescued by Scer\GAL4LL54/AblUAS.GFP
Abl2 is partially rescued by Abl+mTnabl
Abl2 is not rescued by AblK417N.UAS.GFP/Scer\GAL4exex-Gal4
Abl2 is not rescued by Scer\GAL4eg-Mz360/AblUAS.GFP
Abl2 is not rescued by Scer\GAL4eg-Mz360/AblN.UAS.GFP
Expression of AblN.Scer\UAS.T:Avic\GFP in the EW neurons of Abl2 mutant embryos results in a dramatic increase in the number of commissural defects.
Expression of AblN.Scer\UAS.T:Avic\GFP under the control of Scer\GAL4exex-Gal4 exacerbates the ISNb stalling phenotypes found in Abl2 mutant embryos.
Expression of AblScer\UAS.T:Avic\GFP in the EW neurons of Abl2 mutant embryos has no effect on the mild commissural defects found in these mutants.
Expression of AblScer\UAS.T:Avic\GFP under the control of Scer\GAL4exex-Gal4 rescues the ISNb motor axon defects found in Abl2 mutants.
Expression of AblΔFABD.Scer\UAS.T:Avic\GFP under the control of Scer\GAL4exex-Gal4 rescues the ISNb motor axon defects found in Abl2 mutants.
Expression of AblR297K.Scer\UAS.T:Avic\GFP under the control of Scer\GAL4exex-Gal4 rescues the ISNb motor axon defects found in Abl2 mutants.
Expression of AblK417N.Scer\UAS.T:Avic\GFP under the control of Scer\GAL4exex-Gal4 fails to rescue the ISNb motor axon defects found in Abl2 mutants.
When two copies of Ablftz.PH are introduced into Abl2 mutants, axonal crossovers are reduced from 68% in Abl2 single mutants to 37% in the presence of the transgene.
Expression of two copies of AblKN.ftz in Abl2 mutants results in all embryos exhibiting several axon bundles crossing the midline incorrectly.